Study of Different Formulations of an Intramuscular A/H5N1 Inactivated, Split Virion Influenza Adjuvanted Vaccine

NCT00664417 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

375

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza
Orthomyxoviridae Infections

Interventions

BIOLOGICAL: Monovalent subvirion H5N1 influenza vaccine
BIOLOGICAL: Monovalent subvirion H5N1 influenza vaccine
BIOLOGICAL: Monovalent subvirion H5N1 influenza vaccine
BIOLOGICAL: Monovalent subvirion H5N1 influenza vaccine
BIOLOGICAL: Monovalent subvirion H5N1 influenza vaccine
BIOLOGICAL: Monovalent subvirion H5N1 influenza vaccine
BIOLOGICAL: Monovalent subvirion H5N1 influenza vaccine
BIOLOGICAL: Monovalent subvirion H5N1 influenza vaccine
BIOLOGICAL: Physiological saline

Sponsor

Sanofi